These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7614744)
1. [Muscle histopathology and responsiveness to steroid therapy in polymyositis and dermatomyositis]. Imai T; Hirayama K; Osumi E Rinsho Shinkeigaku; 1995 Mar; 35(3):243-6. PubMed ID: 7614744 [TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and muscle histopathology in polymyositis positive anti-hepatitis with C virus antibody]. Ayabe M; Kawamoto M; Ijima H; Hino H; Shoji H Rinsho Shinkeigaku; 1997 Mar; 37(3):208-11. PubMed ID: 9217418 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Lundberg I; Kratz AK; Alexanderson H; Patarroyo M Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873 [TBL] [Abstract][Full Text] [Related]
4. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis. Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334 [TBL] [Abstract][Full Text] [Related]
5. The role of MRI in the assessment of polymyositis and dermatomyositis. Tomasová Studynková J; Charvát F; Jarosová K; Vencovsky J Rheumatology (Oxford); 2007 Jul; 46(7):1174-9. PubMed ID: 17500079 [TBL] [Abstract][Full Text] [Related]
6. Relationships between clinical features and distribution of mononuclear cells in muscle of patients with polymyositis. Kalovidouris AE; Stoesz E; Muller J; Kimes T; Brandt KD J Rheumatol; 1988 Sep; 15(9):1401-6. PubMed ID: 3199400 [TBL] [Abstract][Full Text] [Related]
7. Rituximab as therapy for refractory polymyositis and dermatomyositis. Noss EH; Hausner-Sypek DL; Weinblatt ME J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475 [TBL] [Abstract][Full Text] [Related]
8. A study of morphometric and histopathological features of muscle biopsies from patients of myopathy. Chakrabarti S; Chatterjee U; Sarkar S; Senapati A; Guha D; Mukherjee K Indian J Pathol Microbiol; 2007 Apr; 50(2):288-92. PubMed ID: 17883047 [TBL] [Abstract][Full Text] [Related]
9. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE Arthritis Rheum; 2004 May; 50(5):1586-94. PubMed ID: 15146429 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of oral manifestations and masticatory force in patients with polymyositis and dermatomyositis. Márton K; Hermann P; Dankó K; Fejérdy P; Madléna M; Nagy G J Oral Pathol Med; 2005 Mar; 34(3):164-9. PubMed ID: 15689230 [TBL] [Abstract][Full Text] [Related]
12. Higher proportion of fast-twitch (type II) muscle fibres in idiopathic inflammatory myopathies - evident in chronic but not in untreated newly diagnosed patients. Loell I; Helmers SB; Dastmalchi M; Alexanderson H; Munters LA; Nennesmo I; Lindroos E; Borg K; Lundberg IE; Esbjörnsson M Clin Physiol Funct Imaging; 2011 Jan; 31(1):18-25. PubMed ID: 21029327 [TBL] [Abstract][Full Text] [Related]
13. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory myopathies: evaluation and management. Greenberg SA Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525 [TBL] [Abstract][Full Text] [Related]
15. [Dermatomyositis and polymyositis: the attempt to differentiate and literature review]. Wojas-Pelc A; Lipko-Godlewska S; Bogdaszewska-Czabanowska J Przegl Lek; 2002; 59(1):55-60. PubMed ID: 12108049 [TBL] [Abstract][Full Text] [Related]
16. Tenascin is a useful marker in the diagnosis of inflammatory myopathies. Müller-Felber W; Toepfer M; Müller T; Müller-Höcker J; Fischer P; Lochmüller H; Pongratz D Eur J Med Res; 1998 Jun; 3(6):281-7. PubMed ID: 9620889 [TBL] [Abstract][Full Text] [Related]
17. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis']. Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG; Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600 [TBL] [Abstract][Full Text] [Related]
18. [Serum levels of soluble adhesion molecules in patients with inflammatory myopathies]. Murata K; Takayanagi T; Mano Y; Miyagawa S Rinsho Shinkeigaku; 1996 Jan; 36(1):12-6. PubMed ID: 8689782 [TBL] [Abstract][Full Text] [Related]